Second Sight Medical Products manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight.